Apharma
Goyang-si, KR· latest recorded location
APHARMA is named on 1 US grants and 3 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 1
- Published applications
- 3
- Inventors
- 11
- Granted in 2026 so far
- 0
- Most recent grant
- 26 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year.
Technology areas
Share of 4 documents
- A61PTherapeutic uses of medicines4
- C07KPeptides3
- A61KMedicines and medical preparations2
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2
- G01NInvestigating or analysing materials by determining their chemical or physical properties2
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the2
- A23KFodder1
- A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for1
- A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or1
Recent patents
- Composition for improving insulin sensitivity, containing gentiana trifloral pallas extract25 Jan 2024US 2024/0024402 A1
- Use of itih1 as biomarker for detection of insulin resistance in diseases accompanied by impaired glucose tolerance29 Dec 2022US 2022/0411488 A1
- Antibody specifically recognizing itih1, and pharmaceutical composition containing same for improving insulin resistance in diseases accompanied by impaired glucose tolerance22 Dec 2022US 2022/0403047 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.